Close filter

Ben Maddox

联系信息

+44 207 943 5817

请联系我

Ben Maddox is active globally in Egon Zehnder’s Health Practice. He is an experienced strategic advisor with specialized expertise in pharma, biotech, and life sciences, with a passion for the benefits that science and innovation can bring to patients. Ben leads Executive and Board searches, as well as providing assessment and development support for senior leaders. He has a particular interest in C-suite and R&D leadership roles.

People are at the core of the health sector, both as patients and as leaders. I am energized by finding and developing the best leaders and enabling them to bring exciting scientific innovations to market.

Prior to joining Egon Zehnder, Ben was a Principal at IQVIA. At IQVIA he led the Cambridge, UK office and advised international pharma, biotech, and medical device clients on a wide range of business issues, including pricing and market access, clinical evidence generation, and brand strategy.

He holds a PhD in biochemistry and Masters in Natural Sciences from the University of Cambridge. Ben still lives in Cambridge with his wife and young daughters. Outside of work he enjoys spending time tinkering with technology.

我的专长领域

联系我们
Send Ben a Message
浏览全部
智识与洞见

全球相关顾问

Lyapa Nakazwe-Masiya

Lyapa Nakazwe-Masiya

Los Angeles

Lyapa Nakazwe-Masiya, advises on C-suite and executive board mandates across the US. A member of Egon Zehnder’s Global Consumer, CPI and HR practices… 阅读更多

Keren Latzer

Keren Latzer

Boston

Based in Boston, Keren Latzer is an active member of Egon Zehnder’s Technology, Media & Telecommunications practice, with a specialization in Human… 阅读更多

Sander Markiet

Sander Markiet

Zurich

Sander Markiet is a leadership advisor, based in Zurich. He provides a variety of leadership development-related services such as culture assessments… 阅读更多

Changing language
Close icon

You are switching to an alternate language version of the Egon Zehnder website. The page you are currently on does not have a translated version. If you continue, you will be taken to the alternate language home page.

Continue to the website

Back to top